Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 2/20 | 0.45 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8361114 | 1.00 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL36913 | 1.00 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL13017727 | 1.00 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL1107803 | 1.00 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL3443345 | 1.00 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL21922635 | 1.00 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL5143671 | 1.00 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL13197684 | 1.00 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL22356719 | 1.00 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL15468945 | 1.00 | HSD17B1 (0.45) | HSD17B1HSD17B2ALDH1A1MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100320455-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE, PRODUCTION PROCESS THEREFOR, AND USE THEREOF | SHOWA DENKO K.K. (JP) | 2010-12-23 | — | — | US | disclosed |
| US-20100320455-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE, PRODUCTION PROCESS THEREFOR, AND USE THEREOF | SHOWA DENKO K.K. (JP) | 2010-12-23 | — | — | US | disclosed |
| EP-1342769-B1 | Organic EL Device | TDK CORP (JP) | 2010-01-27 | — | — | EP | disclosed |
| EP-1992672-A1 | Organic electroluminescent device | TDK Corporation (JP) | 2008-11-19 | — | — | EP | disclosed |
| US-20080153019-A1 | ARYLAMINE COMPOUND AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
| US-20080153019-A1 | ARYLAMINE COMPOUND AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
| EP-0857007-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | TDK CORP (JP) | 2004-07-21 | — | — | EP | disclosed |
| EP-1342769-A1 | Organic EL Device | TDK Corporation (JP) | 2003-09-10 | — | — | EP | disclosed |
| US-6603140-B2 | Organic EL device | TDK CORPORATION (JP) | 2003-08-05 | — | — | US | disclosed |
| US-20020038867-A1 | Organic EL device | TDK CORPORATION (JP) | 2002-04-04 | — | — | US | disclosed |
| US-6285039-B1 | HIGH LUMINANCEL CONTINUOUS LIGHT EMISSION AND RELIABILITY; MULTI-COLOR EMISSION MAY BE POSSIBLE | TDK CORPORATION (JP) | 2001-09-04 | — | — | US | disclosed |
| US-6203933-B1 | ELECTROLUMINESCENT ELEMENT WITH LIGHT EMITTER LAYER AND HOLE INJECTING AND TRANSPORTATING COMPOUND | TDK CORPORATION (JP) | 2001-03-20 | — | — | US | disclosed |
| US-5792557-A | ELECTROLUMINESCENCE; TETRAARYLDIAMINE DERIVATIVES; HIGH MELTING POINT; HIGH GLASS TRANSITION TEMPERATURE | TDK CORPORATION (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0857007-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | TDK Corporation (JP) | 1998-08-05 | — | — | EP | disclosed |
| EP-0666298-A2 | Organic EL element and compound used therein | TDK Corporation (JP) | 1995-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153019-A1 | ARYLAMINE COMPOUND AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR | NR2E3, ARRB1, ALDH1A2 | HSD17B1 2304/4885HSD17B2 2396/4885ALDH1A1 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.